Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Expert Opinion on Drug Safety|June 20, 2020
Safety and tolerability of empagliflozin and linagliptin combination therapy in patients with type 2 diabetes mellitus: a pooled analysis of data from five randomized, controlled clinical trialsHirotaka Watada, Toshimasa Yamauchi, Fumiko Yamamoto, et al.
BMC Neurology|November 2, 2019
Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature reviewKazuhiro Ishii, Fumiko Yamamoto, Shinsuke Homma, et al.
Expert Opinion on Drug Safety|October 29, 2021
Safety and tolerability of linagliptin in Asians with type 2 diabetes: a pooled analysis of 4457 patients from 21 randomized, double-blind, placebo-controlled clinical trialsKeizo Kanasaki, Shen Qu, Fumiko Yamamoto, et al.
Neuroscience|January 25, 2019
TFEB-mediated Enhancement of the Autophagy-lysosomal Pathway Dually Modulates the Process of Amyloid β-Protein Generation in NeuronsFumiko Yamamoto, Kaori Taniguchi, Naomi Mamada, et al.
Molecular Brain|February 1, 2017
The neurotoxicity of amyloid β-protein oligomers is reversible in a primary neuron modelDaisuke Tanokashira, Naomi Mamada, Fumiko Yamamoto, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 20, 2020
Cost-Effectiveness Analysis of Linagliptin in Japan Based on Results from the Asian Subpopulation in the CARMELINA<sup>®</sup> TrialHirotaka Watada, Hiroyuki Sakamaki, Daisuke Yabe, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|April 25, 2008
Prediction of clinical outcome in patients with idiopathic thrombocytopenic purpura by evaluating bone marrow clot CD20+ B lymphocytes and morphological changes of megakaryocytesFumiko Yamamoto, Hiroto Narimatsu, Masafumi Ito, et al.
The Journal of Molecular Diagnostics : JMD|April 17, 2023
Comparison of Real-Time PCR and Digital PCR for Detection of Plasma Epstein-Barr Virus DNA in Nasopharyngeal CarcinomaJacob A Miller, ChunHong Huang, Fumiko Yamamoto, et al.
Neuroscience Research|March 8, 2022
Amyloid-β oligomers interact with NMDA receptors containing GluN2B subunits and metabotropic glutamate receptor 1 in primary cortical neurons: Relevance to the synapse pathology of Alzheimer's diseaseKaori Taniguchi, Fumiko Yamamoto, Akiko Amano, et al.
Expert Opinion on Drug Safety|March 12, 2021
Effects of anti-diabetes medications on cardiovascular and kidney outcomes in Asian patients with type 2 diabetes: a rapid evidence assessment and narrative synthesisTakashi Kadowaki, Fumiko Yamamoto, Yusuke Taneda, et al.
Pageof 5